Y-Mabs Therapeutics Inc
XNAS: YMAB
Y-Mabs Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...
Read More
8.51
-0.01
(-0.12%)
2.8M
XNAS Volume
High volume today
XNAS 08 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Y-Mabs Therapeutics Inc is on 12 Aug 2025 for the purpose of Y-mAbs Therapeutics Inc Second Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Y-Mabs Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..